Treatment
Chimeric Natural Killer Receptor Universal T-cells clinical trials
We’re tracking 3 recruiting studies that include Chimeric Natural Killer Receptor Universal T-cells, each written for real people, not researchers, below.
Recruiting studies
- NCT06750133RecruitingPhase 1
CNK-UT cell therapy for steroid-resistant graft-versus-host disease
This trial tests a new cell therapy called CNK-UT for people with severe graft-versus-host disease (aGVHD) that hasn't improved with steroid treatment after a stem cell transplant. The goal is to see if it can help control the immune reaction.
Fuzhou, FujianAges 14–70 - NCT06568328RecruitingPhase 1
Experimental cell therapy for severe graft-versus-host disease
This trial tests a new immune cell treatment for people with severe graft-versus-host disease (GVHD) that hasn't improved with standard medications like ruxolitinib. The goal is to see if these special cells can calm the immune attack and help manage symptoms.
Fuzhou, FujianAges 1–70 - NCT06751134RecruitingPhase 1
Engineered immune cells for relapsed neuroblastoma in children
This trial tests a new type of immune cell therapy (called CNK-UT) for children whose neuroblastoma has come back or hasn't responded to standard treatments. The goal is to see if these cells can find and attack the cancer. Participation may be an option if your child's tumor has a specific marker (B7-H3) and their overall health is stable enough.
Nanjing, JiangsuAges 1–12
What Chimeric Natural Killer Receptor Universal T-cells is being studied for
Conditions with recruiting Chimeric Natural Killer Receptor Universal T-cells studies.
Common questions
- Are there clinical trials studying Chimeric Natural Killer Receptor Universal T-cells?
- Yes. Clin2 currently lists 3 recruiting studies that include Chimeric Natural Killer Receptor Universal T-cells, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Chimeric Natural Killer Receptor Universal T-cells trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Chimeric Natural Killer Receptor Universal T-cells an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Chimeric Natural Killer Receptor Universal T-cells or a specific trial is right for you.
Related treatments
- Cytokine-Induced Memory-like Natural Killer Cells
- chimeric antigen receptor gene modified T cells
- Cytokine-induced Killer Cells
- T cell injection targeting CD7 chimeric antigen receptor
- CAR-T cells
- CD19 CAR-T cells
- Mesenchymal Stem Cells
- anti-CD19 CAR-T cells
- Human Umbilical Cord Mesenchymal Stem Cells
- anti-CD19 CAR NK cells
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.